首页> 外文OA文献 >Vancomycin use in a brazilian teaching hospital: comparison with the Hospital Infection Controlpractices Advisory Committee Guidelines (HICPAC)
【2h】

Vancomycin use in a brazilian teaching hospital: comparison with the Hospital Infection Controlpractices Advisory Committee Guidelines (HICPAC)

机译:巴西教学医院使用万古霉素:与《医院感染控制实践咨询委员会指南》(HICPAC)的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study describes vancomycin prescribing patterns in an average complexity hospital and compare the guidelines proposed by the Hospital Infection Control Practices Advisory Committee (HICPAC). The study was conducted in a 256-bed secondary-care hospital. Data were collected of all patients given vancomycin from March 2003 to February 2004, using a standardized chart-extraction form designed. Appropriate and inappropriate use was reviewed according to the Hospital Infection Control Practices Advisory Committee (HICPAC) guidelines on prudent vancomycin use. Out of 118 prescriptions, 95 (80.5%) were considered appropriate. Out of these 95 orders, 77 (81.1%) were administered for empiric treatment of suspected Gram-positive infections, 17 (17.9%) were administered for treatment of proven Gram-positive infections (76.5% identified as Staphyloccocus aureus-like agents) and 1 (1.0%) for beta-lactam allergy. The majority of the patients (96.6%) had recently used an antimicrobial medication (3 months). The mean pre-treatment hospitalization period was 11±10 days. Out of the 118 treatments, 67 (56.8%) were for nosocomial infections. The more frequent indications for vancomycin use were pneumonia (48.3%) and primary sepsis (18.6%), accounting for more than 66% of all treatments. No restriction policy was suggested because vancomycin use was considered adequate in the majority of the treatment cases. The broad empiric use of this antimicrobial was greater than expected in the institution and its use should be revised.
机译:这项研究描述了一般复杂性医院中万古霉素的处方模式,并比较了医院感染控制实践咨询委员会(HICPAC)提出的指南。该研究在拥有256张床位的二级保健医院中进行。使用设计的标准化图表提取表,收集了2003年3月至2004年2月接受万古霉素治疗的所有患者的数据。根据谨慎使用万古霉素的医院感染控制实践咨询委员会(HICPAC)指南,对适当和不适当的使用进行了审查。在118张处方中,有95张(80.5%)被认为是适当的。在这95份医嘱中,有77份(81.1%)给予了可疑革兰氏阳性感染的经验治疗,有17份(17.9%)给予了已证实的革兰氏阳性感染(76.5%鉴定为金黄色葡萄球菌样病原体)的治疗,对β-内酰胺过敏为1(1.0%)。大多数患者(96.6%)最近使用了抗微生物药物(3个月)。治疗前平均住院时间为11±10天。在118种治疗中,有67种(56.8%)用于医院感染。使用万古霉素的更常见指征是肺炎(48.3%)和原发性败血症(18.6%),占所有治疗的66%以上。没有建议限制措施,因为在大多数治疗病例中万古霉素的使用被认为是足够的。该抗菌剂的广泛经验性使用超出了该机构的预期,应对其使用进行修订。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号